Kathryn Schultz
Rush University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kathryn Schultz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:33 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03285568 · Patterns of Prescribing and Monitoring of PalbociclibRush University Medical Center · completed · Metastatic Breast Cancer, Advanced Breast Cancer, Estrogen Receptor-positive Breast Cancer · principal investigator
- Ph3NCT02939287 · Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose MelphalanRush University Medical Center · completed · Nausea, Vomiting · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:33 UTC. The ranking covers the 200 most relevant of 78 PubMed records, and a shared surname and initials can bring in a namesake. All 78 on PubMed
- Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.J Clin Oncol · 2009499 citationsRCR 10.4
- 403 citationsRCR 11.1
- Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.J Clin Oncol · 2010388 citationsRCR 9.7
- 322 citationsRCR 11.7
- Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study.J Clin Oncol · 2021290 citationsRCR 19.0
- Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.J Clin Oncol · 2021231 citationsRCR 14.2
- Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.J Clin Oncol · 2020224 citationsRCR 10.0
- One-unit versus two-unit cord-blood transplantation for hematologic cancers.N Engl J Med · 2014210 citationsRCR 6.5
- 194 citationsRCR 5.9
- 193 citationsRCR 6.7